This report builds on a workshop sponsored by ASPE, titled Addressing the Opioid Epidemic: Harnessing the Power of Data for Patient-Centered Research in December 2018, which showcased projects working to build the data infrastructure for patient-centered outcomes research around opioids.
Prescription Drugs & Other Medical Products
Drugs and other medical products greatly impact human health and the health care system. ASPE conducts a variety of research in this area, including work related to medical product development and regulation; medical product markets, pricing and competition; prescription drug benefits and spending on medical products; medical product supply chains; and medical product safety.
Noteworthy
Reports
Displaying 41 - 50 of 136. 10 per page. Page 5.
Advanced SearchReport to Congress
Report to Congress: Prescription Drug Pricing Report
September 25, 2019
The Secretary of Health and Human Services (HHS) has been directed to submit a drug pricing report containing information requested by the House Committee on Appropriations.
Report to Congress
Report to Congress: Prescription Drugs: Innovation, Spending, and Patient Access
September 25, 2019
This Report responded to a request from the House and Senate Committees on Appropriations.
Non-Fatal Opioid Overdose and Associated Health Outcomes: Final Summary Report
September 3, 2019
Non-fatal opioid overdose (NFOO) is a significant cause of opioid-related morbidity in the United States. As the number of NFOOs continues to grow, it is important to understand the short- and long-term consequences of NFOO.
Psychosocial Supports in Medication-Assisted Treatment: Recent Evidence and Current Practice
July 7, 2019
ABSTRACT
This report was included as Appendix B of "Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions." That report's purpose was to gain a better understanding of the role and range of different models of psychosocial support in medication-assisted treatment for opioid use disorder.
ASPE Issue Brief
Optimal Utilization of Psychosocial Supports in Medication-Assisted Treatment for Opioid Use Disorder Issue Brief
July 7, 2019
Westat Printer Friendly Version in PDF Format (3 PDF pages)
Report
Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions
July 7, 2019
The purpose of this report is to gain a better understanding of the role and range of different models of psychosocial support in medication-assisted treatment for opioid use disorder.
Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions
July 2, 2019
July 2019
Printer Friendly Version in PDF Format (47 PDF pages)
ASPE Issue Brief
Optimal Utilization of Psychosocial Supports in Medication-Assisted Treatment for Opioid Use Disorder Issue Brief
July 2, 2019
As the opioid epidemic has evolved into a national crisis, the need for treatment has increased greatly. Medication-assisted treatment (MAT) is a “whole-patient” approach to the treatment of opioid use disorder (OUD) that combines the use of medications and psychosocial supports, such as therapy, counseling, self-help groups, and case management.
Choice Matters: Housing Models that May Promote Recovery for Individuals and Families Facing Opioid Use Disorder
June 23, 2019
The purpose of the Opioid Use Disorder, Housing Instability and Housing Options for Recovery project was to help ASPE and HUD describe the housing models available for individuals with Opioid Use Disorder (OUD) who experience housing instability or homelessness.